Glucofort Reviews

Glucofort Reviews: Does It Work? What to Know First Before Buy Friday, October 1, 2021 3:35pm NATIONAL MARKETPLACE A high level of blood sugar is a concerning health issue affecting a vast number of people. This can be because of a poor lifestyle, genetics, or lack of physical movement. The blood sugar level increases and causes damage to other body organs if left uncontrolled for a longer period. Patients who wish to overcome this health issue can choose the natural supplement GlucoFort and get positive results. Glucofort is a herbal and natural dietary supplement to maintain healthy blood sugar in the body. It contains a beneficiary formula that claims to help in keeping the glucose levels at the normal range. It not only gives support to decrease blood sugar but also helps increase insulin production in the body. So, does this supplement can help in controlling the glucose levels of the body? Here, we will review the product and find out all the bits and pieces of information about its use, ingredients, benefits, side effects, price, and many more. Glucofort, reviewed in the IPS News here, is a natural health supplement that may help you in lowering the influence of diabetes. This all-natural supplement helps revitalize the affected body, lowers the sugar levels in the blood, and burns the accumulated body fat. Plus, this new natural and herbal formula comes in a container pack in capsule form. Each dose ensures to eliminate piling up of sugar molecules in the blood. In addition, the organic ingredients present in Glucofort helps to get rid of potential health risks. How Does Glucofort Work? During diabetes, the blood sugar levels increase and reach an abnormal level from which it begins to accumulate inside the body in the form of fat molecules. Over the years, it leads to the cause of obesity and other harmful health diseases. According to the Glucofort website, this all-natural supplement helps to target specific molecules, called ceramide, that stimulate the fat molecules in accumulating and firming the arteries. However, it is to remember that these fat molecules are hazardous for your body. The reason being that they can damage other vital organs, including the liver, heart, and pancreas. The Glucofort capsules target the ceramide molecules and eliminate them from the inside system. Subsequently, when the ceramide levels decrease, the fat accumulation around the other organs tends to lessen. After that, the pancreas again becomes productive in regulating the incoming sugar molecules in the body. Again, the vitamins and minerals present in the Glucofort formula supplement the body with vital nutrients. The nutrient-packed formula boosts flushing out of the toxins from the body and restores the blood cells. Additionally, it claims to nourish vital organs and reduces the threat of cardiovascular disease. When you consume this product consistently, you will observe how your body naturally utilizes the excess glucose. What are the Ingredients in Glucofort? The Glucofort formula includes a proprietary blend of natural ingredients, including trees, berries, roots, bark, and plants. Each of these ingredients is a derivation of the Tibetan Culture, where they blend all these and drink them as herbal tea. Although these ingredients are hard to obtain by international users, Glucofort makes it easy by bringing them together in capsules. Now, let us have a look at the ingredients and their benefits. Guggul Guggul or Mukul Myrrh is an Indian-origin ingredient. Its potent properties are available in the resin that helps to improve both cholesterol levels and triglycerides. Thus, it plays a substantial role in lowering the risk of prediabetic and acquiring diabetes phase. Bitter Melon Perhaps one of the ancient ingredients used to fight abnormal blood sugar levels in the history of Indian and African medicines. Bitter Melon is a real plant that is rich in vitamin C and comes with several benefits. It claims to stimulate insulin activity in the body and reduce glucose levels. Therefore, Glucofort uses this natural plant to regulate glucose levels in the body. Licorice Root Licorice is a type of flowering plant that is full of antioxidants. Their roots are beneficial in the prevention and reversion of diabetes symptoms. In addition, it acts as a natural sweetener in the formula and improves heart health, insulin response, and reduces fat. Gymnema Sylvestre Gymnema Sylvestre is a vital ingredient of the Glucofort supplement that protects people from diabetes and other complications related to the disease. Cinnamon Cinnamon is a flavourful ingredient used in several meals and drinks to enhance its aroma. The formula of Glucofort comprises this ingredient because it can improve glucose levels and reduce blood triglycerides. Besides, cinnamon is great for handling insulin resistance in patients with diabetes. Yarrow Extract The extracts of yarrow flowers stimulate insulin production inside the body and fight against high blood sugar levels. As a result, it provides adequate insulin to metabolize the sugar molecules that circulate in the blood. Cayenne Pepper Cayenne Pepper has loads of capsaicin in it that mainly boosts to reduce fat layers from the body. As a result, this ingredient helps to cure obesity and energies the body in the process. Juniper Berries The lookalikes of blueberries, juniper berries contain extraordinary benefits. It provides relief from high sugar levels, reduces cholesterol, and improves heart complications. L-taurine This amino acid can boost fat absorption and prevent accumulating around the pancreas. Further, it discourages any disturbance in the production of insulin and offers relief from diabetes symptoms. White Mulberry White mulberry works effectively in controlling symptoms of diabetes and prevents sugar accumulation in the arteries. Miscellaneous Ingredients Apart from the important ingredients, Glucofort uses other ingredients in its formula. Biotin (300mcg) Magnesium (125mg) Chromium (76mcg) Vitamin C (50mg) Vitamin E (15mg) Zinc (7.5mg) Manganese (1mg) The official website of Glucofort claims to derive its ingredients only from natural sources and use no chemical stimulants to intensify the effects. image 1 How to Consume Glucofort Using this natural supplement is simple and convenient. The brand asks you to consider Glucofort as a daily multivitamin capsule. As this health supplement comes in a capsule shape, you may consume it every day by gulping a capsule with a glass of water in the evening. Is it safe to use? Are there any Underlying Side Effects? Each of the ingredients is FDA certified and made following the GMP standards. The manufacturer avoids using fillers, chemicals, or stimulants in the composition. Hence, they are likely to be a safe supplement. However, the brand emphasizes the varying results on different users. Furthermore, most reviews online state that it is a safe supplement that may not have any side effects when consumed following the official guidelines. Who Can Use and Not Use Glucofort Glucofort supplement is suitable for adults of all genders. Nonetheless, Glucofort works better for middle-aged consumers who are prone to the risk of acquiring imbalance levels of sugar and diabetes type 2. Since this is a health supplement for 18+ and above, underage people must refrain from using it. Similarly, people dealing with underlying ailments, including heart disease, must consult with their physician before including this product in their daily routine. Here is a list of groups of people who cannot take this product. Underage People The brand clearly states that Glucofort is a natural health supplement for adult use only. Hence, all individuals below 18 years of age must avoid taking these capsules even if they are diagnosed with diabetes. Pregnant and Nursing Woman All women out there who have currently conceived or breastfeeding their baby should not consume Glucofort supplements. It is ideal to consult your doctor to get suggestions about your sugar imbalance complication. As this two-period is particularly delicate, you must take the advice of a relevant doctor instead of consuming this diabetes supplement. If you have been diagnosed with co-existing diseases, it is better to consult a physician before you choose to incorporate this into your daily routine. Otherwise, Glucofort may deteriorate their condition. If you are already under-prescribed or non-prescribed medication, you must avoid it without consulting your physician. Consumption of these capsules may cross-react to the other drugs and put your life at risk. If you are allergic to any ingredients present in the composition of Glucofort, avoid the supplement. It may otherwise result in allergic reactions. Purchase GlucoFort Glucofort is not available in stores. You can order it from their official website https://glucofort.com/ and treat your disease. You can get exciting deals on the products. Although the price of Glucofort is higher, the official website runs amazing deals on their products. Currently, the basic 30 days supply bottle costs $69, the premium 180 days supply bottle costs $49, and the popular 90 days supply bottle costs $59 after discount. image 2 What is the Glucofort return policy? Glucofort product offers an easy 60-day money-back return policy if the supplement does not work in favor. Contact the customer service team with questions; customers can do so by direct messaging at: https://glucofort.com/pages/contact/ Final Thoughts Glucofort is an all-natural supplement that users can consume daily to help stabilize blood sugar levels, as per recommended doses. So, if you are an adult who needs help controlling blood sugar, and is tired of spending thousands, try Glucofort. Consume the product for a month at least and see how well it works for you. Otherwise, you can ask for a refund. More Like This: Gluco20 Reviews – Blood Sugar Fix Supplement Scam or Legit? Affiliate Disclosure: The links contained in this product review may result in a small commission if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products. Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease.

Victor Lin .Ph.D.,Assistant Professor of...Jazz Studies ,Faculty of COLUMBIA COLLEGE

The Administration and Faculty of Columbia College COLUMBIA COLLEGE http://bulletin.columbia.edu/columbia-college/administration-faculty-columbia-college/ Victor Lin Assistant Professor of... Faculty GENERAL STUDIES http://bulletin.columbia.edu/general-studies/faculty/ Victor Lin .Ph.D.,Assistant Professor of... Jazz Studies COLUMBIA COLLEGE http://bulletin.columbia.edu/columbia-college/departments-instruction/jazz-studies/ ...Correa Krin Gabbard David Gibson Brad Jones Victor Lin Ole Mathiesen Tony Moreno Ugonna Okegwa... Music COLUMBIA COLLEGE http://bulletin.columbia.edu/columbia-college/departments-instruction/music/ ...Kahn Arthur Kampela James Kerr Louis Kosma Victor Lin Paul-Martin Maki Andrew Milne Tony... Jazz Studies* GENERAL STUDIES http://bulletin.columbia.edu/general-studies/majors-concentrations/jazz-studies/ ...Correa Krin Gabbard David Gibson Brad Jones Victor Lin Ole Mathiesen Tony Moreno Ugonna Okegwa... Music GENERAL STUDIES http://bulletin.columbia.edu/general-studies/majors-concentrations/music/ ...Kahn Arthur Kampela James Kerr Louis Kosma Victor Lin Paul-Martin Maki Andrew Milne Tony... Jazz Studies OverviewFacultyRequirementsCourses Interdepartmental Committee on Jazz Studies Ann Douglas (English and Comparative Literature) Brent Hayes Edwards (English and Comparative Literature) Aaron Fox (Music) Farah Jasmine Griffin (English and Comparative Literature) George Lewis (Music) Robert G. O’Meally (English and Comparative Literature) Christopher Washburne (Music) Adjunct Lecturers in Jazz Performance Paul Bollenbeck Christine Correa Krin Gabbard David Gibson Brad Jones Victor Lin Ole Mathiesen Tony Moreno Ugonna Okegwa Adriano Santos Don Sickler Leo Traversa Ben Waltzer

SARS-CoV-2 Omicron variant

SARS-CoV-2 Omicron variant Jump to navigationJump to search Graphic of a globe with a red analog clock This article documents a current event. Information may change rapidly as the event progresses, and initial news reports may be unreliable. The latest updates to this article may not reflect the most current information. Please feel free to improve this article (but note that updates without valid and reliable references will be removed) or discuss changes on the talk page. (November 2021) (Learn how and when to remove this template message) Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease)SARS-CoV-2 (virus) CasesDeaths Timeline Locations International response Medical response Variants Economic impact and recession Impacts SARS-CoV-2 (Wikimedia colors).svg COVID-19 portal vte The Omicron variant, also known by the PANGO lineage identifier B.1.1.529, GISAID clade identifier GR/484A, and Nextstrain clade identifier 21K,[1] is a variant of SARS-CoV-2, the virus that causes COVID-19. The first known case was detected in Botswana, dated 9 November 2021.[2] On 26 November 2021, the World Health Organization (WHO) designated it as a variant of concern and named it after the Greek letter Omicron.[3][4][5] The variant has an unusually large number of mutations, several of which are novel, and several of which affect the spike protein used for most vaccine targeting at the time of its discovery. This level of variation has led to concerns regarding transmissibility, immune system evasion, and vaccine resistance. As a result, the variant was rapidly designated as being "of concern", and travel restrictions were introduced by several countries to limit or slow its international spread. Contents 1 Classification 1.1 Nomenclature 1.2 Mutations 2 Symptoms 3 Prevention 4 Diagnosis 5 Characteristics 6 Epidemiology 7 Statistics 8 History 8.1 Reported cases 8.2 Market reactions 8.3 International response 9 See also 10 References Classification Nomenclature On 26 November, the WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution designated PANGO lineage B.1.1.529 a variant of concern and gave it the designation Omicron[3][4][5] (skipping Nu or Xi, the next letters in the Greek alphabet).[6][5] The World Health Organization reserves the Omicron designation for "variants of concern".[7][5] The GISAID project has assigned it the clade identifier GR/484A[1] and the Nextstrain project has assigned it the clade identifier 21K.[1] Mutations The variant has a large number of mutations, of which some are concerning.[8] 32 mutations affect the spike protein, the main antigenic target of antibodies generated by infections and of many vaccines widely administered. Many of those mutations had not been observed in other strains.[9][10] The variant is characterised by 30 amino acid changes, three small deletions and one small insertion in the spike protein compared with the original virus, of which 15 are located in the receptor binding domain (residues 319-541). It also carries a number of changes and deletions in other genomic regions. Of note, the variant has three mutations at the furin cleavage site.[11] The furin cleavage site increases SARS-CoV-2 infectivity.[12] The mutations by genomic region are the following:[13][14] Spike protein: A67V, Δ69-70, T95I, G142D, Δ143-145, Δ211, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K[clarification needed], G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K, L981F ORF1ab nsp3: K38R, V1069I, Δ1265, L1266I, A1892T nsp4: T492I nsp5: P132H nsp6: Δ105-107, A189V nsp12: P323L nsp14: I42V Envelope protein: T9I Membrane protein: D3G, Q19E, A63T Nucleocapsid protein: P13L, Δ31-33, R203K, G204R Symptoms Main article: Symptoms of COVID-19 No unusual symptoms have been associated with the variant, and as with other variants, some individuals are asymptomatic.[15] Prevention See also: COVID-19 § Prevention As with other variants, the WHO recommended that people continue to keep enclosed spaces well ventilated, avoid crowding and close contact, wear well-fitting masks, clean hands frequently, and get vaccinated.[3][16] On 26 November, BioNTech said it will know in two weeks whether the current vaccine is effective against the variant and that an updated vaccine can be shipped in 100 days if necessary. AstraZeneca, Moderna and Johnson & Johnson were also studying the variant's impact on the effectiveness of their vaccines.[17] WHO asked nations to do the following: "Enhance surveillance and sequencing efforts to better understand circulating SARS-CoV-2 variants. Submit complete genome sequences and associated metadata to a publicly available database, such as GISAID. Report initial cases/clusters associated with VOC infection to WHO through the IHR mechanism. Where capacity exists and in coordination with the international community, perform field investigations and laboratory assessments to improve understanding of the potential impacts of the VOC on COVID-19 epidemiology, severity, effectiveness of public health and social measures, diagnostic methods, immune responses, antibody neutralization, or other relevant characteristics."[18] Diagnosis See also: COVID-19 testing Current PCR tests can detect the variant. Some laboratories have indicated that a widely used PCR test does not detect one of the three target genes. Just as with the Alpha variant, this partial detection ("S gene target failure") can serve as a marker for the variant, however.[3] Rapid antigen tests are likely not affected.[15] Characteristics Many of the mutations to the spike protein are present in other variants of concern and are related to increased infectivity and antibody evasion. Computational modeling suggests that the variant may also escape cell-mediated immunity.[10] On 26 November, the ECDC wrote that an evaluation of the neutralizing capacity of convalescent sera and of vaccines is urgently needed to assess possible immune escape, saying these data are expected within two to three weeks.[14] Epidemiology The number of cases in the B.1.1.529 lineage is increasing throughout South Africa, mainly in the South Africa province of Gauteng.[8] Some evidence shows that this variant has an increased risk of reinfection. Studies are underway to evaluate the impact on transmissibility, mortality, and other factors. Evidence regarding the implications of this variant and vaccine efficacy is under investigation.[16][19] In 2020, South African infection rates reached a low on 11 November. Cases peaked in mid-January 2021. Similarly in 2021, cases bottomed out on 11 November, before again rising rapidly, growing four-fold by 25 November.[20] There is still vast uncertainty about the transmissibility with respect to the Delta variant, with a possible 100% increase (2x)[21][22] to 500% increase (6x).[23] Statistics GISAID data as of 27 November, unless otherwise stated:[24] Confirmed cases by country Country Confirmed cases South Africa 83 Botswana 17 Hong Kong 2 United Kingdom 2[25] Germany 2[25] Israel 1 Belgium 1 World (7 countries) Total: 108 History Reported cases On 24 November 2021, the variant was first reported to the WHO from South Africa.[3] The first known specimen was collected on 9 November 2021 from Botswana.[10] It was also detected in South Africa;[26] one case had traveled to Hong Kong,[27][28] and one confirmed case was identified in Israel in a traveler returning from Malawi,[29] along with two who returned from South Africa and one from Madagascar.[30] One confirmed case in Belgium had apparently acquired it in Egypt before 11 November.[31] All four initial cases reported from Botswana occurred among fully vaccinated individuals.[32] All three initial confirmed and suspected cases reported from Israel occurred among fully vaccinated individuals,[29] as did the single suspected case in Germany.[33] On 27 November, two cases were detected in the United Kingdom and another two in Munich, Germany.[25] The Dutch health ministry estimated that 61 of the around 600 passengers on two flights from South Africa that had landed at Amsterdam Airport Schiphol on 26 November (which had taken off just before the Netherlands had banned travel from South Africa) tested positive for COVID-19 of as yet unknown variants. Entry into the Netherlands (and thus getting on the flight) generally required having been vaccinated or PCR-tested, or having recovered. One of the flights originated from Johannesburg, Gauteng. Gauteng is where the Omicron variant appears to be dominant already. The passengers of both flights had been tested and quarantined upon arrival because of the newly imposed restrictions.[34] Market reactions Worry about the potential economic impact of the Omicron variant led to a drop in global markets on 26 November, including the worst drop of the Dow Jones Industrial Average in 2021, led by travel-related stocks. The price of Brent Crude and West Texas Intermediate oil fell 10% and 11.7%, respectively. This reaction was described as "overblown" by one market analyst[who?] due to the lack of firm conclusions by the medical community.[35] Cryptocurrency markets were also routed.[36][37] International response On 26 November WHO advised countries not to impose new restrictions on travel, instead recommending a "risk-based and scientific" approach to travel measures.[38] On the same day the European Centre for Disease Prevention and Control (ECDC) reported modeling indicating that strict travel restrictions would delay the variant's impact on European countries by two weeks, possibly allowing countries to prepare for it.[14] Also on the same day, several countries announced travel bans from southern Africa in response to the identification of the variant, including Japan, Canada, the European Union, Israel, Australia, the United Kingdom, Singapore, the United States, and Malaysia.[39][40][41][42] The Brazilian Health Regulatory Agency recommended flight restrictions regarding the new variant.[43] The state of New York declared a state of emergency ahead of a potential Omicron spike, though no cases had yet been detected in the state or the rest of the United States.[44] In response, South African Minister of Health Joe Phaahla defended his country's handling of the pandemic and said that travel bans went against the "norms and standards" of the World Health Organization.[45] See also Variants of SARS-CoV-2 SARS-CoV-2 Beta variant COVID-19 pandemic in Africa COVID-19 vaccination in Africa COVID-19 vaccination in Botswana COVID-19 vaccination in South Africa References "Tracking SARS-CoV-2 variants". www.who.int. Retrieved 27 November 2021. "US to Restrict Flights Over New Heavily Mutated Omicron COVID-19 Variant - November 26, 2021". Daily News Brief. 26 November 2021. Retrieved 27 November 2021. "Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern". World Health Organization. 26 November 2021. Retrieved 26 November 2021. Parekh, Marcus; Platt, Poppie; Team, Global Health Security; Barnes, Joe (26 November 2021). "Coronavirus latest news: EU suspends all flights to southern Africa over omicron Covid variant fears". The Telegraph. ISSN 0307-1235. Retrieved 26 November 2021. Meyer, David (16 November 2021). "What's Omicron? Here's what we know and don't know about the new COVID variant that's roiling markets and air travel". Fortune. Retrieved 26 November 2021. Parekh, Marcus; Platt, Poppie; Team, Global Health Security; Barnes, Joe (26 November 2021). "Coronavirus latest news: EU suspends all flights to southern Africa over omicron Covid variant fears". The Telegraph. ISSN 0307-1235. Retrieved 26 November 2021. "Countries are scrambling to stop a new covid variant". The Economist. 26 November 2021. Retrieved 26 November 2021. Hurst, Luke (26 November 2021). "What we know so far about the B.1.1.529 'Omicron' COVID variant causing concern". Euronews. Retrieved 26 November 2021. Cookson, Clive; Barnes, Oliver (26 November 2021). "What we know about Omicron variant that has sparked global alarm". Financial Times. Retrieved 26 November 2021. Callaway, Ewen (25 November 2021). "Heavily mutated coronavirus variant puts scientists on alert". Nature. doi:10.1038/d41586-021-03552-w. Zimmer, Carl (26 November 2021). "New Virus Variant Stokes Concern but Vaccines Still Likely to Work". New York Times. Retrieved 26 November 2021. Zhang, Liping; Mann, Matthew; Zulfeqhar, Syed; Reynolds, Hayley; Tian, E; Samara, Nadine; Zeldin, Darryl; Tabak, Lawrence (23 November 2021). "Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation". Proceedings of the National Academy of Science of the United States of America. 118 (47): e2109905118. doi:10.1073/pnas.2109905118. PMID 34732583. S2CID 242937417. SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 29 (PDF) (Briefing). Public Health England. 26 November 2021. GOV-10481. Archived (PDF) from the original on 26 November 2021. Retrieved 26 November 2021. "Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA" (PDF). ecdc.europa.eu. Retrieved 26 November 2021. "Frequently asked questions for the B.1.1.529 mutated SARS-CoV-2 lineage in South Africa". NICD. National Institute for Communicable Diseases. 26 November 2021. Retrieved 27 November 2021. Nebehay, Stephanie; Winning, Alexander (26 November 2021). "WHO names new COVID variant omicron, cautions against travel measures". Reuters. Retrieved 26 November 2021. "BioNTech says it could tweak Covid vaccine in 100 days if needed". The Guardian. 26 November 2021. Retrieved 27 November 2021. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern Sample, Ian (24 November 2021). "Scientists warn of new Covid variant with high number of mutations". The Guardian. Retrieved 24 November 2021. "COVID-19 Data Explorer". Our World in Data. Retrieved 26 November 2021. "Omicron variant spreads to Europe as UK announces countermeasures". the Guardian. 26 November 2021. Retrieved 27 November 2021. Health Department briefs media about a new so-called super-variant, retrieved 27 November 2021 "New COVID variant possibly 500 percent more infectious than Delta". Newsweek. 26 November 2021. Retrieved 27 November 2021. "Tracking of Variants". GISAID. Updated frequently. "Omicron coronavirus variant detected in UK and Germany, concern triggers travel curbs". Reuters. 27 November 2021. Retrieved 27 November 2021. "Lineage: Mutation Tracker: s:S371L Mutation Report". outbreak.info. Retrieved 26 November 2021. Covid: New heavily mutated variant B.1.1.529 in South Africa raises concern, 25 November 2021, BBC News, accessed 25 November 2021 Tracking SARS-CoV-2 variants (Tables: Currently designated Variants Under Monitoring -describes 529 variant as present in 'Multiple countries'- and 'Formerly monitored variants'- B.1.523 & B.1.619 Reclassified Nov 2021). www.who.int, accessed 25 November 2021 @BNODesk (26 November 2021). "Statement from Israel's health ministry reporting 1 confirmed case of new coronavirus variant B.1.1.529" (Tweet). Retrieved 26 November 2021 – via Twitter. 14:30 4 מאומתים לווריאנט החדש התגלו בארץ, רה"מ יקיים מסיבת עיתונאים translated: "...Verified for the new strain 4 verified for the new variant were discovered in the country...", m.ynet.co.il, accessed 26 November 2021 Reuters (26 November 2021). "Belgium detects first case of new COVID-19 variant in Europe". Reuters. Retrieved 26 November 2021. Four cases of the new COVID-19 variant recorded in Botswana, 25 November 2021, Mmegi Online, accessed 26 November 2021 Kerstin Kesselgruber (27 November 2021). "Flughafen Frankfurt: Person mit Omikron-Verdacht war vollständig geimpft" [Frankfurt airport: Person suspected to be infected with omicron variant was fully vaccinanted]. Frankfurter Rundschau (in German). Archived from the original on 27 November 2021. Retrieved 27 November 2021. "61 travellers from South Africa in Netherlands positive for COVID-19 -authorities". Reuters. Amsterdam. 27 November 2021. Retrieved 27 November 2021. Gregg, Aaron (26 November 2021). "Dow plunges more than 900 points as new coronavirus variant sends global markets reeling". Washington Post. Retrieved 26 November 2021. "Bitcoin and other crypto plunge as fear of new COVID variant routs markets". Fortune. https://www.euronews.com/next/2021/11/26/bitcoin-price-drops-8-amid-fears-of-covid-b-1-1-529-variant-discovered-in-south-africa-her "WHO cautions against imposing travel restrictions due to new variant". Reuters. Geneva. 26 November 2021. Retrieved 26 November 2021. Yong, Clement (26 November 2021). "Singapore bans travellers from 7 African countries; no cases of new Covid-19 variant here". The Straits Times. Singapore. Retrieved 26 November 2021. Linskey, Annie (26 November 2021). "U.S. to restrict travel from South Africa and other countries as it assesses risks of new omicron variant". Washington Post. Retrieved 26 November 2021. Walsh, Marieke; Stone, Laura (26 November 2021). "COVID-19 variant of concern Omicron causes Canada to impose restrictions on travel from southern parts of Africa". The Globe and Mail. Retrieved 26 November 2021. Daim, Nuradzimmah; Harun, Hana (26 November 2021). "Temporary entry ban on foreign travellers following discovery of heavily mutated Covid-19 variant". New Straits Times. Archived from the original on 26 November 2021. Retrieved 27 November 2021. Anvisa recomenda restrições de voo diante de nova variante de covid-19 26 November 2021 agenciabrasil.ebc.com.br, accessed 27 November 2021 Kennedy, Mark; Price, R. Darren. "'It's Coming': NY Declares State of Emergency Ahead of Potential Omicron Spike". NBC New York. Retrieved 27 November 2021. Winning, Alexander; Cocks, Tim (26 November 2021). "South Africa says travel bans over new variant unjustified". Reuters. Archived from the original on 26

H. pylori finds its home

H. pylori finds its home Oct 12, 2016 iBiology 135K subscribers https://www.ibiology.org/microbiology... Most microorganisms cannot survive in the hostile environment of the stomach. But, what happens when bacteria survives the gastric lumen and are able to call the stomach its home? Dr. Julie Huang tells us the story of H. pylori, eccentric bacteria that are able to colonize human stomach. These bacteria are the leading cause of stomach ulcers in humans and are associated with stomach cancer. Huang discovered TlpB, a chemoreceptor in H. pylori that enables bacteria to detect suitable environments and thereafter “swim” toward their home, the epithelial cells. She showed that TlpB detects the presence of urea, allowing H. pylori to find a more neutral environment where it can survive. This demonstrates that bacteria not only can sense potentially harmful cues, like low pH, but can also react to favorable factors, like urea, when finding their new home. This innovative understanding on how H. pylori find their niche opens new routes to develop novel approaches to prevent stomach ulcers and cancer. Speaker Biography: Dr. Julie Huang completed her Bachelor degree at the California Institute of Technology. Given her scientific merits, she was granted a Fulbright scholarship in 2009 to work at the Max Planck Institute for Marine Microbiology in Germany. After this experience, Huang joined the Microbiology and Immunology doctorate program at Stanford University, where she started to work with Dr. Manuel Amieva. At Stanford, she studied how the pathogen H. pylori survive in the stomach. Her outreach interests led her to be involved in different mentoring initiatives, including co-founding the Stanford First Gen/Low-Income (FLI) Undergraduate Mentoring Program.